| Primary |
| Depression |
36.1% |
| Product Used For Unknown Indication |
28.3% |
| Major Depression |
7.0% |
| Drug Use For Unknown Indication |
6.1% |
| Bipolar Disorder |
5.3% |
| Hypertension |
3.7% |
| Sleep Disorder |
3.3% |
| Endometriosis |
2.0% |
| Parkinsonism |
1.2% |
| Antiretroviral Therapy |
0.8% |
| Hiv Infection |
0.8% |
| Hypothyroidism |
0.8% |
| Initial Insomnia |
0.8% |
| Intentional Self-injury |
0.8% |
| Prophylaxis |
0.8% |
| Bipolar Disorder |
0.4% |
| Depression |
0.4% |
| Abdominal Discomfort |
0.4% |
| Abdominal Pain |
0.4% |
| Anxiety |
0.4% |
|
| Suicide Attempt |
19.1% |
| Tachycardia |
10.4% |
| Tremor |
9.6% |
| Memory Impairment |
8.7% |
| Somnolence |
7.0% |
| Vomiting |
6.1% |
| Psoriasis |
5.2% |
| Visual Impairment |
5.2% |
| Suicidal Ideation |
4.3% |
| Weight Increased |
3.5% |
| Overdose |
2.6% |
| Sleep Disorder |
2.6% |
| Thrombocytopenia |
2.6% |
| Visual Acuity Reduced |
2.6% |
| Alanine Aminotransferase Increased |
1.7% |
| Angina Pectoris |
1.7% |
| Convulsion |
1.7% |
| Death |
1.7% |
| Depression |
1.7% |
| Lipase Increased |
1.7% |
|
| Secondary |
| Product Used For Unknown Indication |
39.6% |
| Depression |
12.3% |
| Major Depression |
10.4% |
| Drug Use For Unknown Indication |
9.4% |
| Apathy |
3.8% |
| Prophylaxis |
3.8% |
| Psychiatric Symptom |
3.8% |
| Foetal Exposure During Pregnancy |
2.8% |
| Rheumatoid Arthritis |
2.8% |
| Drug Abuse |
1.9% |
| Fatigue |
1.9% |
| Hepato-lenticular Degeneration |
1.9% |
| Intentional Overdose |
1.9% |
| Salivary Hypersecretion |
1.9% |
| Common Migraine |
0.9% |
| Multiple Sclerosis |
0.9% |
|
| Serotonin Syndrome |
10.8% |
| Tremor |
10.8% |
| Hepatic Enzyme Increased |
8.1% |
| Pain |
8.1% |
| Small For Dates Baby |
8.1% |
| Umbilical Cord Abnormality |
8.1% |
| Parkinsonism |
5.4% |
| Psychomotor Hyperactivity |
5.4% |
| Restlessness |
5.4% |
| Suicide Attempt |
5.4% |
| Tachycardia |
5.4% |
| Death |
2.7% |
| Dermatitis Allergic |
2.7% |
| Drug Interaction |
2.7% |
| Intentional Overdose |
2.7% |
| Pregnancy |
2.7% |
| Vertigo |
2.7% |
| Weight Decreased |
2.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
47.8% |
| Depression |
26.1% |
| Relapsing-remitting Multiple Sclerosis |
6.5% |
| Attention Deficit/hyperactivity Disorder |
4.3% |
| Ill-defined Disorder |
4.3% |
| Multiple Sclerosis |
4.3% |
| Hypothyroidism |
2.2% |
| Rheumatoid Arthritis |
2.2% |
| Schizoaffective Disorder Depressive Type |
2.2% |
|
| Restless Legs Syndrome |
18.2% |
| Thrombocytopenia |
18.2% |
| Drug Exposure During Pregnancy |
9.1% |
| Reversible Ischaemic Neurological Deficit |
9.1% |
| Deep Vein Thrombosis |
4.5% |
| Meningitis |
4.5% |
| Metastases To Liver |
4.5% |
| Multiple Sclerosis Relapse |
4.5% |
| Pleurothotonus |
4.5% |
| Renal Failure Chronic |
4.5% |
| Rheumatoid Arthritis |
4.5% |
| Somnolence |
4.5% |
| Syncope |
4.5% |
| Tibia Fracture |
4.5% |
|
| Interacting |
| Product Used For Unknown Indication |
69.2% |
| Hypertension |
11.5% |
| Depression |
7.7% |
| Diuretic Therapy |
5.8% |
| Major Depression |
5.8% |
|
| Sinus Tachycardia |
30.8% |
| Toxicity To Various Agents |
23.1% |
| Tongue Biting |
15.4% |
| Drug Interaction |
7.7% |
| Grand Mal Convulsion |
7.7% |
| Parkinsonism |
7.7% |
| Psychomotor Hyperactivity |
7.7% |
|
